Aurora, Colo. (April 5, 2017) – UCHealth and RxRevu are launching an innovative Prescription Decision Support platform that provides additional data to physicians at the point of prescribing medications to treat heart failure (HF) conditions. This additional prescribing information can increase accuracy, improve patient outcomes and decrease the cost of care, and it comes one year after the organizations started a sponsored research pilot program to develop the high-tech RxCheck platform which is fully-integrated into UCHealth’s electronic health record (EHR).
The program will initially go live in select UCHealth primary care clinics, and goals include:
- Supporting clinicians in prescribing the best and most current evidence-based medications,
- Improving the patient-provider experience, and
- Generating usage data to improve future heart failure treatment
RxCheck is a prescription support solution that integrates seamlessly into current clinician workflows and leverages patient data, claims, formularies, cost data and protocols to provide providers with real-time clinical decision support. “By utilizing our Prescription Decision Support platform, providers can identify and prescribe the right medications the first time, saving time, reducing clinical variability and improving outcomes. UCHealth has been a valued development partner for us, and we’re excited to deliver our PDS platform across UCHealth’s network of hospitals and clinics for heart failure patients,” says RxRevu CEO Carm Huntress about the partnership.
There are 30 or more commonly prescribed medications for heart failure patients, and often, a patient needs a combination of medications to best treat the condition. The RxRevu platform analyzes multiple data fields from the patient’s health record, best practice recommendations and cost to help determine the best course of treatment for the patient.
“The right drug, for the right patient, the first time,” said Dr. Rich Zane, UCHealth chief innovation officer and professor and chair of Emergency Medicine at the CU School of Medicine. “Having this data at our fingertips is better and easier for providers, better for health insurers and, most importantly, better for patients.”
This program is part of a growing partnership between the two entities, focusing on improving prescribing accuracy for multiple conditions related to cardiology. “It is impossible for a provider to be an expert on every medication for every disease and to immediately prescribe the best option. Using clinical decision support to analyze big data, RxRevu will help improve patient care and safety while reducing wasted medication and lowering cost,” said Robert Harrison, RN, BC-NI and artificial intelligence Ph.D. at UCHealth. Using RxCheck, UCHealth will also accelerate heart failure research.
This project was made possible through the Colorado Office of Economic Development and International Trade (OEDIT) Early Stage Capital and Retention grant.
RxRevu, through its RxCheck platform, provides critical information to clinicians prescribing medications to patients at the point of care. Today, prescribers are making complex purchasing decisions on their patients’ behalf. Key information is missing in the electronic health record system to support evidence-based prescribing. The RxCheck platform from RxRevu leverages real-time Prescription Decision Support (PDS) to optimize prescribing behavior, facilitate prospective prior-authorization and navigate fulfillment choice.
UCHealth is an innovative, nonprofit health system that delivers the highest quality medical care with an excellent patient experience. UCHealth combines Memorial Hospital, Poudre Valley Hospital, Medical Center of the Rockies, UCHealth Medical Group, Broomfield Hospital, Grandview Hospital and University of Colorado Hospital into an organization dedicated to health and providing unmatched patient care in the Rocky Mountain West. With more than 100 clinic locations, UCHealth pushes the boundaries of medicine, providing advanced treatments and clinical trials and improving health through innovation.